期刊文献+

b型流感嗜血杆菌结合疫苗冻干剂型的研究 被引量:6

Development of the freeze-dried Haemophilus influenza type b (Hib) conjugate vaccine
下载PDF
导出
摘要 对b型流感嗜血杆菌结合疫苗冻干剂型进行了研制。选用2.5%的甘氨酸作为稳定剂对疫苗进行冻干,对冻干疫苗的抗原性、免疫原性和安全性等理化特性和免疫学特性进行了检定,并与同类疫苗进行比较。各项检定结果及系统观察表明:冻干疫苗安全性良好,抗原性及免疫原性没有发生改变。与同类疫苗相比,针对HibCPS抗原的IgG抗体及针对TT抗原的抗体水平具有相同的变化趋势。冻干疫苗稳定性较冻干前明显变好,效期可延长至3年;不仅有利于保存和运输,而且方便与其他疫苗联合使用。 The freeze-dried Haemophilus influenza type b ( Hib ) polysaccharide protein conjugate vaccine was developed. The vaccine was freeze-dried using 2.5% glycine as a stabilizer. The properties, the antigenicity, immunogenicity, safety and physical-chemical properties of the freeze-dried vaccine were detected by comparison with other similar vaccines. The results showed that the freeze-dried vaccine is of excellent safety and there are no changes in antigenicity and immunogenici- ty. Comparing with the liquid vaccine, the titer changes of anti-Hib CPS IgG and anti-q3" antibody are similar. The stability of freeze-dried vaccine is better, and the term of validity can be prolonged to three years.
出处 《微生物学免疫学进展》 2010年第2期1-8,共8页 Progress In Microbiology and Immunology
关键词 Hib-TT结合疫苗 冻干 甘氨酸 免疫原性 Hib-TT conjugate vaccine Freeze-dried Glycine Immunogenicity
  • 相关文献

参考文献11

  • 1靳志刚,杨辉,田玉珍,谭小梅,蒲江,张谦,沈玉霖,王永谦,谢贵林,王秉瑞,李凤祥,何莉,袁曾麟.b型流感嗜血杆菌结合疫苗的制备及免疫学特性[J].中国生物制品学杂志,2000,13(1):19-22. 被引量:8
  • 2谢贵林,谭小梅,杜琳,等.b型流感嗜血杆菌结合疫苗的研制及应用[R].预防医学学科发展蓝皮书,2006.
  • 3WHO.Requirements for Haemophilus Type b conjugate vaccines (requirements for biological substances No.46)[S].Technical Report Series No.814.1991.15-37.
  • 4Schneerson R,Barrera O,Sutton A,et al.Preparation,characterization and immunogenicity of Haemophilus Iufluenzae type b polysaccharide-protein conjugates[J].Jexp Med 1980,152:361-376.
  • 5Schneerson R,Robbins JB,Chu C,et al.Serum antibody responses of juvenile and infant rhesus monkeys injected with Hib and pneumococcus type 6A polysaccharide-protein conjugates[J].Imfect Immun1984,45:582-591.
  • 6Schneerson R,Robbins JB,Szu SC,et al.Vaccines composed of polysaccharide-protein conjugates:current status,unanswerer questions and prospects for the future[M].In towords better carbohydrate vaccines (ed Bell R and G Torrigiani),John Wiley and Sons.New York,1986.307-327.
  • 7樊培禄 罗安甫 张绛萼.儿童之细菌性脑膜炎[J].中华医学,1943,29:41-51.
  • 8黄达枢.婴儿感冒杆菌脑膜炎[J].中华儿科杂志,1955,6(2):116-119.
  • 9欧阳旭明 丁载道.流行性感冒杆菌脑膜炎120例临床分析[J].中华儿科杂志,1957,8(1):1-5.
  • 10曹玉璞,董庆华.肺炎球菌和流感嗜血杆菌脑膜炎快速诊断方法的研究[J].中华儿科杂志,1989,27(2):96-98. 被引量:6

二级参考文献5

共引文献16

同被引文献43

  • 1黄镇,钱雯,李文春,林建祥,王云学,陈燕,陈南萍,刘红岩.C群脑膜炎球菌多糖蛋白结合疫苗衍化工艺研究[J].预防医学情报杂志,2005,21(4):397-400. 被引量:4
  • 2杨美峰,范泉水,戴晓畅,黄镇,刘红岩.A群脑膜炎球菌多糖蛋白结合疫苗衍化工艺的研究[J].西南国防医药,2006,16(6):583-585. 被引量:1
  • 3World Health Organization. WHO Expert Committee on Bio- logical Standardization. Forty-first Report [S]. World Health Organ Tech Rep Ser, 1991, 814:15-37.
  • 4谢贵林,谭小梅,杜琳,等.b型流感嗜血杆菌结合疫苗的研制及应用[A]//中华预防医学.预防医学学科发展蓝皮书-2006卷.北京:中华预防医学会,2006:136-137.
  • 5Sturgess AW, Rush K. Charbonneau R J, et al. Haemophilus influenzae type b conjugate vaccine stability: catalytic depoly- merization of PRP in the presence of aluminum hydroxide [J]. Vaccine, 1999, 17(9/10) : 1169-1 178.
  • 6Schneerson R, Barrera O, Sutton A, et al. Preparation,characterization and immunogenicity of Haernophilus influenzae type b polysaccharide-protein conjugates [J]. J Exp Med, 1980, 152(2): 361-376.
  • 7Schneerson R, Robbins JB, Chu C, et al. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates[J],Infect Immun, 1984, 45(3): 582-591.
  • 8Jones C, Crane DT, Lemercinier X, et al. Physicochemieal studies of the structure and stability of polysaecharide-protein conjugate vaccines [J]. Dev Biol Stand, 1996, 87:143-15L.
  • 9Townsend K,Ladhani SN,Findlow H,et al.Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection[J].Vaccine,2014,32(43):5650-5656.
  • 10WHO.WHO requirements for Haemophilus type b conjugate vaccines(requirements for biological substances No46)[S].Technical Report Series,1991(814):15-37.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部